Evidence map›Paper›PMID 37097030›Full record

ArticlemBio2023

The Timing and Magnitude of the Type I Interferon Response Are Correlated with Disease Tolerance in Arbovirus Infection.

Alexandra Hardy, Siddharth Bakshi, Wilhelm Furnon, Oscar MacLean, Quan Gu, Margus Varjak, Mariana Varela, Muhamad Afiq Aziz, Andrew E Shaw, Rute Maria Pinto and 8 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. MITD1 is a brain-specific interferon-inducible factor that inhibits flavivirus replication.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Comprehensive immune profiling reveals thatFrontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Alexandra HardyMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Siddharth Bakshi *MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Wilhelm Furnon *MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Oscar MacLeanMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Quan GuMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Margus VarjakMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Mariana VarelaMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Muhamad Afiq AzizMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Andrew E ShawMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Rute Maria PintoMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Natalia Cameron RuizMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Catrina MullanMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Aislynn E TaggartMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Ana Da Silva FilipeMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Richard E RandallSchool of Biology, Centre for Biomolecular Sciences, University of St. Andrews, St. Andrews, Fife, United Kingdom.ORCID 0000-0002-9304-6678
Sam J WilsonMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.ORCID 0000-0002-6065-0895
Meredith E StewartMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Massimo PalmariniMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.ORCID 0000-0001-7007-4070
MRC University of Glasgow Centre for Virus Research · GBUniversity of St Andrews · GB

Funding

Medical Research Council MC_UU_00034/3Medical Research Council MC_UU_00034/8Medical Research Council MC_UU_12014/10Medical Research Council MC_UU_12014/12Medical Research Council MC_UU_12016/10
6 · The paper itself

Abstract

Infected hosts possess two alternative strategies to protect themselves against the negative impact of virus infections: resistance, used to abrogate virus replication, and disease tolerance, used to avoid tissue damage without controlling viral burden. The principles governing pathogen resistance are well understood, while less is known about those involved in disease tolerance. Here, we studied bluetongue virus (BTV), the cause of bluetongue disease of ruminants, as a model system to investigate the mechanisms of virus-host interactions correlating with disease tolerance. BTV induces clinical disease mainly in sheep, while cattle are considered reservoirs of infection, rarely exhibiting clinical symptoms despite sustained viremia. Using primary cells from multiple donors, we show that BTV consistently reaches higher titers in ovine cells than cells from cattle. The variable replication kinetics of BTV in sheep and cow cells were mostly abolished by abrogating the cell type I interferon (IFN) response. We identified restriction factors blocking BTV replication, but both the sheep and cow orthologues of these antiviral genes possess anti-BTV properties. Importantly, we demonstrate that BTV induces a faster host cell protein synthesis shutoff in primary sheep cells than cow cells, which results in an earlier downregulation of antiviral proteins. Moreover, by using RNA sequencing (RNA-seq), we also show a more pronounced expression of interferon-stimulated genes (ISGs) in BTV-infected cow cells than sheep cells. Our data provide a new perspective on how the type I IFN response in reservoir species can have overall positive effects on both virus and host evolution.

Indexed as

BluetongueInterferon Type IAnimalsAntiviral AgentsCattleFemaleSheepViremiaAntiviral AgentsInterferon Type Iarbovirusdisease toleranceinnate immunityinterferons

Identifiers

PMID37097030
PMCPMC10294695
OpenAlexW4366984710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.